Swedish Orphan International’s business concept is to develop and supply orphan drugs – drugs designated for the treatment of rare, life-threatening or chronically debilitating diseases.
Swedish Orphan International was founded in 1988 and is a pioneer within the area of orphan drugs. Swedish Orphan International has for several years been one of Sweden’s fastest growing companies, and now has affiliates throughout Europe.
